RecruitingPhase 2NCT06679634

Retinoblastoma Phase II Expanded Access Clinical Trial

Sponsor

Targeted Therapy Technologies, LLC

Enrollment

30 participants

Start Date

Feb 21, 2025

Study Type

INTERVENTIONAL

Conditions

Retinoblastoma

Summary

In this research study investigators want to learn more about treatment of advanced or recurrent retinoblastoma. For children with retinoblastoma that have an advanced stage of presentation in one eye or if they have failed all conventional treatment, eye removal is considered. This study will investigate the utility of a chemoplaque(s) to salvage eyes involved with retinoblastoma. The goal of the study is to further determine/assess the safety and efficacy and optimal chemotherapy dose for retinoblastoma.

Eligibility

Max Age: 8 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Chemoplaque also referred to as Episcleral Topotecan for people with retinoblastoma. The study is currently recruiting participants at 2 locations. People eligible for this study include up to age 8 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.